HRT Financial’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-448
Closed -$3K – 3105
2025
Q3
$3K Sell
448
-316
-41% -$3.08K ﹤0.01% 2764
2025
Q2
$5K Buy
+764
New +$11.5K ﹤0.01% 2484
2024
Q3
– Sell
-1,169
Closed -$33K – 2335
2024
Q2
$33K Sell
1,169
-262
-18% -$9.9K ﹤0.01% 1881
2024
Q1
$47K Buy
+1,431
New +$53.6K ﹤0.01% 1938
2023
Q1
– Sell
-50
Closed -$6K – 2420
2022
Q4
$6K Buy
+50
New +$8.76K ﹤0.01% 2258

Other funds holding AZR

HRT Financial's AZR Position: Q4 2025 in Review

HRT Financial sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q4 2025, closing a stake of 448 shares — an estimated $3K sold.

HRT Financial first reported a position in AZR in Q4 2022 and held it in 5 quarters. The position peaked at $47K in Q1 2024. 23 funds tracked by Wall St. Rank hold AZR as of Q4 2025.

  • HRT Financial reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 448 Azora Therapeutics, Inc. Common Stock shares in Q4 2025, an estimated $3K.
  • HRT Financial first reported a position in Azora Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • HRT Financial's Azora Therapeutics, Inc. Common Stock position peaked at $47K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.